Format
Sort by
Items per page

Send to

Choose Destination

Best matches for CELL TRANSPLANTATION:

Treatment of Parkinson's disease using cell transplantation. Lindvall O et al. Philos Trans R Soc Lond B Biol Sci. (2015)

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Passweg JR et al. Bone Marrow Transplant. (2016)

Cell Transplantation: Science at the Highest Level. Sanberg PR et al. Cell Transplant. (2016)

Search results

Items: 1 to 20 of 267830

1.

Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.

Jarvis KB, LeBlanc M, Tulstrup M, Nielsen RL, Albertsen BK, Gupta R, Huttunen P, Jónsson ÓG, Rank CU, Ranta S, Ruud E, Saks K, Trakymiene SS, Tuckuviene R, Schmiegelow K.

Thromb Res. 2019 Nov 7;184:92-98. doi: 10.1016/j.thromres.2019.11.002. [Epub ahead of print]

PMID:
31715544
2.

Immunotherapy and other systemic therapies for cutaneous SCC.

Guminski A, Stein B.

Oral Oncol. 2019 Nov 9;99:104459. doi: 10.1016/j.oraloncology.2019.104459. [Epub ahead of print]

PMID:
31715538
3.

Biofabrication of microcapsules encapsulating beta-TC-6 cells via scalable device and in-vivo evaluation in type 1 diabetic mice.

Bansal A, D'Sa S, D'Souza MJ.

Int J Pharm. 2019 Nov 9:118830. doi: 10.1016/j.ijpharm.2019.118830. [Epub ahead of print]

PMID:
31715349
4.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Newell LF, DeFor TE, Cutler C, Verneris MR, Blazar BR, Miller JS, Antin JH, Howard A, Wu J, MacMillan ML, Panoskaltsis-Mortari A, Weisdorf DJ, Holtan SG.

Biol Blood Marrow Transplant. 2019 Nov 9. pii: S1083-8791(19)30746-3. doi: 10.1016/j.bbmt.2019.11.006. [Epub ahead of print]

PMID:
31715306
5.

Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.

Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Nov 9. pii: S1083-8791(19)30741-4. doi: 10.1016/j.bbmt.2019.11.001. [Epub ahead of print]

PMID:
31715305
6.

Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.

Takahashi K, Ota Y, Kogure T, Suzuki Y, Iwamoto H, Yamakita K, Kitano Y, Fujii S, Haneda M, Patel T, Ota T.

Cancer Sci. 2019 Nov 12. doi: 10.1111/cas.14232. [Epub ahead of print]

PMID:
31715081
7.

In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: a new tool to characterize the alloimmune response.

Calvani J, Terada M, Lesaffre C, Eloudzeri M, Lamarthée B, Burger C, Tinel C, Anglicheau D, Vermorel A, Couzi L, Loupy A, Duong Van Huyen JP, Bruneval P, Rabant M.

Am J Transplant. 2019 Nov 12. doi: 10.1111/ajt.15699. [Epub ahead of print]

PMID:
31715060
8.

Applicability, Safety And Biological Activity Of Regulatory T Cell Therapy In Liver Transplantation.

Sánchez-Fueyo A, Whitehouse G, Grageda N, Cramp ME, Lim TY, Romano M, Thirkell S, Lowe K, Fry L, Heward J, Kerr A, Ali J, Fisher C, Lewis G, Hope A, Kodela E, Lyne M, Farzaneh F, Kordasti S, Rebollo-Mesa I, Jose Lozano J, Safinia N, Lechler R, Martínez-Llordella M, Lombardi G.

Am J Transplant. 2019 Nov 12. doi: 10.1111/ajt.15700. [Epub ahead of print]

PMID:
31715056
9.

A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009 - 2015.

Valentine JC, Morrissey CO, Tacey MA, Liew D, Patil S, Ananda-Rajah M.

Mycoses. 2019 Nov 12. doi: 10.1111/myc.13033. [Epub ahead of print]

PMID:
31715052
10.

Large-scale Production of LGR5-positive Bipotential Human Liver Stem Cells.

Schneeberger K, Sánchez-Romero N, Ye S, van Steenbeek FG, Oosterhoff LA, Pla Palacin I, Chen C, van Wolferen ME, van Tienderen G, Lieshout R, Colemonts-Vroninks H, Schene I, Hoekstra R, Verstegen MMA, van der Laan LJW, Penning LC, Fuchs SA, Clevers H, De Kock J, Baptista PM, Spee B.

Hepatology. 2019 Nov 12. doi: 10.1002/hep.31037. [Epub ahead of print]

PMID:
31715015
11.

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.

Arruda LCM, Gaballa A, Uhlin M.

Blood Adv. 2019 Nov 12;3(21):3436-3448. doi: 10.1182/bloodadvances.2019000682.

PMID:
31714966
12.

Microbiota modification in hematology: still at the bench or ready for the bedside?

Severyn CJ, Brewster R, Andermann TM.

Blood Adv. 2019 Nov 12;3(21):3461-3472. doi: 10.1182/bloodadvances.2019000365.

PMID:
31714965
13.

Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.

Huang QS, Wang JZ, Qin YZ, Zeng QZ, Jiang Q, Jiang H, Lu J, Liu HX, Liu Y, Wang JB, Su L, Zhang HY, Li ZL, Gao SJ, Huang B, Liu YY, Liu YR, Xu LP, Huang XJ, Zhang XH.

Blood Adv. 2019 Nov 12;3(21):3406-3418. doi: 10.1182/bloodadvances.2019000564.

PMID:
31714962
14.

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.

Bader P, Salzmann-Manrique E, Balduzzi A, Dalle JH, Woolfrey AE, Bar M, Verneris MR, Borowitz MJ, Shah NN, Gossai N, Shaw PJ, Chen AR, Schultz KR, Kreyenberg H, Di Maio L, Cazzaniga G, Eckert C, van der Velden VHJ, Sutton R, Lankester A, Peters C, Klingebiel TE, Willasch AM, Grupp SA, Pulsipher MA.

Blood Adv. 2019 Nov 12;3(21):3393-3405. doi: 10.1182/bloodadvances.2019000449.

PMID:
31714961
15.

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Thol F, Platzbecker U.

Blood Adv. 2019 Nov 12;3(21):3449-3453. doi: 10.1182/bloodadvances.2018022434.

PMID:
31714960
16.

Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.

Iliopoulou BP, Hsu K, Pérez-Cruz M, Tang SW, Pang WW, Erkers T, Kambham N, Freeman GJ, Dekruyff RH, Meyer EH.

Blood Adv. 2019 Nov 12;3(21):3419-3431. doi: 10.1182/bloodadvances.2019000286.

PMID:
31714958
17.

Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy.

Schaub NJ, Hotaling NA, Manescu P, Padi S, Wan Q, Sharma R, George A, Chalfoun J, Simon M, Ouladi M, Simon CG Jr, Bajcsy P, Bharti K.

J Clin Invest. 2019 Nov 12. pii: 131187. doi: 10.1172/JCI131187. [Epub ahead of print]

PMID:
31714897
18.

Human Autologous iPSC-Derived Dopaminergic Progenitors Restore Motor Function in Parkinson's Disease Models.

Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen B, Teicher M, Leblanc P, Carter B, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS.

J Clin Invest. 2019 Nov 12. pii: 130767. doi: 10.1172/JCI130767. [Epub ahead of print]

PMID:
31714896
19.

Salvage therapy for relapsed testicular cancer: a need for consensus.

Agrawal V, Adra N.

Future Oncol. 2019 Nov 12. doi: 10.2217/fon-2019-0531. [Epub ahead of print] No abstract available.

PMID:
31714157
20.

Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival.

Finazzi MC, Boschini C, Craddock C, Rambaldi A, Ward J, Malladi RK.

Br J Haematol. 2019 Nov 12. doi: 10.1111/bjh.16200. [Epub ahead of print]

PMID:
31713861

Supplemental Content

Loading ...
Support Center